Business Description
Biocept Inc
NAICS : 621511
SIC : 8731
ISIN : US09072V4023
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.57 | |||||
Equity-to-Asset | 0.01 | |||||
Debt-to-Equity | 39.97 | |||||
Debt-to-EBITDA | -0.4 | |||||
Piotroski F-Score | 1/9 | |||||
Beneish M-Score | -10.11 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -17 | |||||
3-Year EBITDA Growth Rate | 46.5 | |||||
3-Year EPS without NRI Growth Rate | 45 | |||||
3-Year FCF Growth Rate | 58.3 | |||||
3-Year Book Growth Rate | -36.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 38.95 | |||||
14-Day RSI | 40.3 | |||||
6-1 Month Momentum % | -99.78 | |||||
12-1 Month Momentum % | -100 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.81 | |||||
Quick Ratio | 1.7 | |||||
Cash Ratio | 1.35 | |||||
Days Inventory | 28.7 | |||||
Days Sales Outstanding | 2003.03 | |||||
Days Payable | 57.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -46.1 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -1055.02 | |||||
Operating Margin % | -2445.28 | |||||
Net Margin % | -2257.23 | |||||
FCF Margin % | -1347.86 | |||||
ROE % | -213.89 | |||||
ROA % | -82.63 | |||||
ROIC % | -156.96 | |||||
ROC (Joel Greenblatt) % | -160.49 | |||||
ROCE % | -99.37 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.16 | |||||
EV-to-EBITDA | -0.17 | |||||
EV-to-Revenue | 3.66 | |||||
EV-to-Forward-Revenue | 0.97 | |||||
EV-to-FCF | -0.27 | |||||
Earnings Yield (Greenblatt) % | -625 | |||||
FCF Yield % | 3.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BIOCQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Biocept Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.356 | ||
EPS (TTM) ($) | -50.9 | ||
Beta | 25.93 | ||
Volatility % | 150 | ||
14-Day RSI | 40.3 | ||
14-Day ATR ($) | 0.00011 | ||
20-Day SMA ($) | 0.0001 | ||
12-1 Month Momentum % | -100 | ||
52-Week Range ($) | 0.0001 - 2.3886 | ||
Shares Outstanding (Mil) | 2.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 1 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Biocept Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Biocept Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Biocept Inc Frequently Asked Questions
What is Biocept Inc(BIOCQ)'s stock price today?
When is next earnings date of Biocept Inc(BIOCQ)?
Does Biocept Inc(BIOCQ) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |